the market?
XOMA Limited
NASDAQ: XOMA
4.19
0.01
(0.24%)
| Today's Open | $4.18 |
|---|---|
| Previous Close | $4.18 |
| Daily Range | $4.17 - $4.29 |
| 52-Week Range | $2.25 - $4.40 |
| Market Cap | $347.3M |
| P/E Ratio | -5.89 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 144,612 |
| Average Daily Volume | 783,845 |
| Current FY EPS | -$0.82 |
How do you think XOMA
will perform against the market?
Top XOMA Bull/Bear Pitches
zzlangerhans (< 20)
Submitted
April 18, 2011
Did I get the thumb right this time? Hopefully I won't regret it. Xoma's recent failure to demonstrate benefit of 052 in diabetes has set up an interesting situation. As of the end of 2010, the compa … More
BrianRuth (< 20)
Submitted
March 5, 2007
Calling BS on this one. It would be great if they could help cancer with recombinant whatever, but I think 9 out of 10 microcap companies in this space will go bankrupt.
News & Commentary
3 Humongous Health-Care Stocks This Week
Encouraging clinical study results, revenue growth, and a CEO change propelled these stocks to double-digit gains this week.Stock Upgrades: Green Mountain Scales the Summit
Wall Street ratings agencies set the tone for today's stock market.Is This the Next Investing Bubble?
The Nasdaq Biotechnology Index recently hit a record high. Does that mean that biotech investors are in a bubble?Top Insider Trades: XOMA and AGCO Insiders Buy
Meanwhile Schwab and Google insiders sell.XOMA Shares Up 150%, but in the Wrong Way
XOMA shares fall hard on news of additional dilution.Sector
Healthcare
Industry
Drugs
XOMA Limited (XOMA) Description
A biopharmaceutical company that discovers, develops and manufactures antibodies and other genetically-engineered protein products to treat immunological and inflammatory disorders, cancer and infectious diseases. Website: http://www.xoma.com/
CEO Rating by Glassdoor
More details for XOMA Jobs
XOMA reviews from employees
